| | Start date | Site | Title | Topic |
|---|
| ML25113A262 | 28 August 2025 | | Special Inspection Charter to Evaluate Potential Radiation Overexposure at Curium Pharma Noblesville, Indiana | Overexposure
Reactive Inspection |
| ML25087A147 | 16 June 2025 | | Consolidated Technical Analysis Table - Lv Liberty Vision Yttrium-90 Brachytherapy Source | Brachytherapy |
| ML25050A097 | 9 April 2025 | | Enclosure - Consolidated Technical Analysis | Brachytherapy |
| ENS 57657 | 8 April 2025 19:18:00 | Curium Pharma | Possible Overexposure Due to Loss of Control of Licensed Material | Overexposure |
| ML24338A041 | 4 February 2025 | | Consolidated Technical Analysis Alpha Dart, Rev. 1 21 Nov 24 | Brachytherapy |
| ML24325A441 | 10 December 2024 | | Eye90 Microspheres 35.1000 Consolidated Technical Analysis | Brachytherapy |
| ML24247A253 | 27 September 2024 | | Eye90 Microspheres Consolidated Technical Analysis | Brachytherapy |
| STC-24-051, Notification of Issuance of Akesis Galaxy Rti Gamma Stereotactic Radiotherapy Licensing Guidance | 29 August 2024 | | STC-24-051 Notification of Issuance of Akesis Galaxy Rti Gamma Stereotactic Radiotherapy Licensing Guidance | Brachytherapy |
| ML24239A781 | 29 August 2024 | | Enclosure 2 - Akesis Galaxy 35.1000 Consolidated Technical Analysis | Brachytherapy |
| ML24206A038 | 23 August 2024 | | Akesis Galaxy 35.1000 Consolidated Technical Analysis | Brachytherapy |
| ML24031A609 | 31 January 2024 | | FY2023 Nuclear Material Event Database (NMED) Annual Report | Deep Dose Equivalent
Pandemic
COVID-19
Brachytherapy
Stolen
Backfit
Exit Sign
Overexposure
Reactive Inspection
Basic Component |
| ML24033A303 | 23 January 2024 | | Draft for ACMUI Review - Interim Staff Guidance NMSS-ISG- Guidance for the Implementation of 10 CFR Part 25 Training & Experience Requirements - Draft for Comment | |
| ML23284A132 | 27 November 2023 | | OMB-3150-0010 - Final Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material 2023 | Brachytherapy |
| ML23320A242 | 16 November 2023 | | Ots Chapter 246-231 Wac Package Transportation (002) | Condition Adverse to Quality
Exclusive Use
Depleted uranium |
| ML23241A914 | 23 August 2023 | | T180-13 Effective 2021-04-05 Highlighted | Incorporated by reference
Condition Adverse to Quality
Exclusive Use
Depleted uranium |
| ML23241A917 | 23 August 2023 | | T180-13 Effective 2022-11-02 Highlighted | Incorporated by reference
Condition Adverse to Quality
Exclusive Use
Depleted uranium |
| ML23052A201 | 19 July 2023 | | Regulatory Placement Evaluation for Civaderm | Brachytherapy
Eye plaque |
| ML23167A360 | 14 June 2023 | | Wac Chapter 246-231 Packaging and Transportation of Radioactive Material | Condition Adverse to Quality
Exclusive Use
Depleted uranium |
| ML23137A012 | 5 June 2023 | | OMB-3150-0010 - Draft Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material (2023) | Brachytherapy |
| ML24045A274 | 31 March 2023 | | G 2023 Rev 1-24 Final - Use of Radionuclides in the Healing Arts | License Renewal
Brachytherapy |
| ENS 56343 | 7 February 2023 05:00:00 | Ge Healthcare South Plainfield, Nj | Source Lost in Transit | Moisture Density Gauge |
| ML22326A362 | 22 November 2022 | | Draft Regulatory Basis Document for the Rulemaking to Establish Requirements for Rubidium-82 Generators and Emerging Medical Technologies for ACMUI Review | Enforcement Discretion
Decommissioning Funding Plan
Exemption Request
Brachytherapy
TheraSphere |
| ML22306A137 | 1 November 2022 | | MD Regulations Supplement 32 | Tritium Exit Sign
High Radiation Area
Cyber Security
Incorporated by reference
Brachytherapy
Static Eliminator
Stolen
Depleted uranium
Basic Component |
| ML22223A178 | 11 August 2022 | | VA Amended Regulations 12VAC5-481 | Cyber Security
Brachytherapy |
| ENS 56001 | 18 July 2022 05:00:00 | Houston Methodist Hospital | Unable to Locate Licensed Material | Moisture Density Gauge |
| ML22131A271 | 9 May 2022 | | Georgia Regulations Markup 2021 | High Radiation Area
Incorporated by reference
License Renewal
Earthquake
Brachytherapy
Exclusive Use
Overexposure
Depleted uranium |
| ML22097A076 | 30 March 2022 | | Maryland Regulations Supplement 32 Draft | Tritium Exit Sign
High Radiation Area
Cyber Security
Incorporated by reference
Brachytherapy
Static Eliminator
Stolen
Depleted uranium |
| ML22018A223 | 10 March 2022 | | Alphadart 35.10000 Consolidated Technical Analysis | Brachytherapy |
| ML22066A310 | 4 March 2022 | | CRCPD Part T | Exclusive Use
Depleted uranium |
| ML22173A148 | 14 December 2021 | 07103091 | Redacted - IS-DS 2651 - Design, Manufacturing and Operating Specification for the F-522 Family of Transport | Liquid penetrant |
| ML21301A027 | 25 October 2021 | | Tennessee Regulations 0400-20-07 | License Renewal
Brachytherapy |
| ML22173A184 | 20 September 2021 | 07103091 | Redacted - Certificate No. CDN/2094/B(U)-96, Revision 4, Package No. F-522 (Docket No. 71-3091) | Depleted uranium |
| ML21193A320 | 7 July 2021 | | Nd Chapter 33.1-10-13.1 | Incorporated by reference
Condition Adverse to Quality
Uranium Hexafluoride
Exclusive Use
Depleted uranium |
| ENS 55326 | 24 June 2021 22:00:00 | Curium Pharma | Unplanned Contamination to an Individual | Deep Dose Equivalent |
| ENS 55101 | 9 February 2021 17:00:00 | Metaphysics/Ge Healthcare | Lost Generator | Moisture Density Gauge |
| ML20303A306 | 27 October 2020 | | Ks Cross Reference 2015-3, Revisions to Transportation Safety Requirements and Harmonization with International Atomic Energy Agency Transportation Requirements; Including Corrections | Incorporated by reference
Depleted uranium |
| ML20261H508 | 3 September 2020 | | Nd Regulations 33.1-10-13.1 | Incorporated by reference
Condition Adverse to Quality
Uranium Hexafluoride
Exclusive Use
Depleted uranium |
| ML20128J890 | 30 June 2020 | | OMB-3150-0010 - Supporting Statement - 10 CFR Part 35 Medical Use of Byproduct Material | Brachytherapy |
| ENS 54711 | 13 May 2020 12:00:00 | Curium Pharma | Fire Involving Loss of Integrity of Licensed Container | |
| ML20118D014 | 30 April 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) April 30, 2020 Teleconference Meeting Ebinder | Enforcement Discretion
Exemption Request
Pandemic
COVID-19
TheraSphere |
| ML20115E395 | 30 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30, 2020 Meeting Ebinder, Revised | Brachytherapy
Stolen
TheraSphere
Overexposure
Overdose
Reactive Inspection |
| ML20115E343 | 30 March 2020 | | NRC Staff Medical Event Slides, March 30, 2020, FY19 Events | Brachytherapy
TheraSphere
Overdose |
| VR-SECY-20-0018, Report to Congress on Abnormal Occurrences: Fiscal Year 2019 (Caputo) | 27 March 2020 | | VR-SECY-20-0018: Report to Congress on Abnormal Occurrences: Fiscal Year 2019 (Caputo) | Deep Dose Equivalent
Brachytherapy
Stolen
Overexposure
Overdose
Reactive Inspection |
| ML20078M712 | 18 March 2020 | | Advisory Committee on the Medical Uses of Isotopes (ACMUI) March 30, 2020 Meeting Ebinder | Brachytherapy
Stolen
TheraSphere
Overexposure
Overdose |
| ML19344D378 | 18 February 2020 | | OMB-3150-0010 - Draft Supporting Statement for 10 CFR Part 35 Medical Use of Byproduct Material | Brachytherapy |
| SECY-20-0002, Weekly Information Report - Week Ending December 27, 2019 | 14 January 2020 | | SECY-20-0002: Weekly Information Report - Week Ending December 27, 2019 | License Renewal
Subsequent License Renewal Application |
| Information Notice 2019-11, Strontium-82/Rubidium-82 Generator Elution Events and Issues | 23 December 2019 | | Strontium-82/Rubidium-82 Generator Elution Events and Issues | |
| ML19276E405 | 2 October 2019 | | Louisiana Cross Reference 2015-3 | Incorporated by reference
Depleted uranium |
| ML19210D823 | 23 July 2019 | | Maine Regulations 10-144 CMR Ch. 220 Part G | License Renewal
Brachytherapy
TheraSphere |
| ML19085A550 | 26 March 2019 | | Staffs Presentation to Agreement States and Their Licensees on the 10 CFR Parts 30, 32, and 35 Rulemaking | Brachytherapy |